| # | Drug | Count |
|---|---|---|
| 0 | BUPIVACAINE | 6 |
| 1 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 6 |
| 2 | FENTANYL | 5 |
| 3 | FENTANYL CITRATE | 2 |
| 4 | ADALIMUMAB | 1 |
| 5 | APIXABAN | 1 |
| 6 | ASFOTASE ALFA | 1 |
| 7 | BUPIVACAINE HYDROCHLORIDE | 1 |
| 8 | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | 1 |
| 9 | CARBOPLATIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | 1 | 0.0022 |
| 1 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 6 | 0.0008 |
| 2 | BUPIVACAINE | 6 | 0.0006 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 4 | FENTANYL CITRATE | 2 | 0.0001 |
| 5 | ASFOTASE ALFA | 1 | 0.0001 |
| 6 | FENTANYL | 5 | 0.0001 |
| 7 | CEFTRIAXONE SODIUM | 1 | 0.0000 |
| 8 | VANCOMYCIN | 1 | 0.0000 |
| 9 | APIXABAN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Amide Local Anesthetic [EPC] | 6 |
| 1 | Opioid Agonist [EPC] | 5 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 3 | Glycopeptide Antibacterial [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 1 | Amide Local Anesthetic [EPC] | 6 | 0.0001 |
| 2 | Opioid Agonist [EPC] | 5 | 0.0000 |
| 3 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |